Stay updated on Pembrolizumab Maintenance in sNSCLC Clinical Trial

Sign up to get notified when there's something new on the Pembrolizumab Maintenance in sNSCLC Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Pembrolizumab Maintenance in sNSCLC Clinical Trial page

  1. Check
    5 days ago
    Change Detected
    Summary
    The page revision was updated from v3.3.3 to v3.3.4 without changes to study content or navigation. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.1%
    Check dated 2026-01-14T02:58:53.000Z thumbnail image
  2. Check
    12 days ago
    No Change Detected
  3. Check
    19 days ago
    No Change Detected
  4. Check
    26 days ago
    Change Detected
    Summary
    Footer updates display Revision: v3.3.3 and removal of the HHS Vulnerability Disclosure link along with Revision: v3.3.2, a non-significant change; To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.1%
    Check dated 2025-12-23T20:37:24.000Z thumbnail image
  5. Check
    55 days ago
    Change Detected
    Summary
    Revision updated from v3.2.0 to v3.3.2 on the page.
    Difference
    0.1%
    Check dated 2025-11-24T21:33:01.000Z thumbnail image
  6. Check
    62 days ago
    Change Detected
    Summary
    A notice regarding potential delays and outdated information due to a lapse in government funding has been removed.
    Difference
    0.4%
    Check dated 2025-11-17T19:52:33.000Z thumbnail image
  7. Check
    77 days ago
    Change Detected
    Summary
    Both screenshots depict the same ClinicalTrials.gov record for NCT02564380, with no changes to core information like title, sponsor, location, eligibility criteria, or outcomes; any differences are limited to layout/visual formatting. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.4%
    Check dated 2025-11-03T13:52:25.000Z thumbnail image
  8. Check
    105 days ago
    Change Detected
    Summary
    Major update: page now includes a funding-related operating status notice and announces version 3.2.0, replacing v3.1.0.
    Difference
    3%
    Check dated 2025-10-06T04:24:56.000Z thumbnail image

Stay in the know with updates to Pembrolizumab Maintenance in sNSCLC Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Pembrolizumab Maintenance in sNSCLC Clinical Trial page.